Changes of Hepatitis B Virus Dna in Liver and Serum Caused by Recombinant Leukocyte Interferon Treatment: Analysis of Intrahepatic Replicative Hepatitis B Virus Dna
Open Access
- 1 September 1985
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 5 (5), 728-734
- https://doi.org/10.1002/hep.1840050505
Abstract
Twenty patients with HBeAg–positive chronic liver disease were given large doses of recombinant leukocyte interferon for 4 weeks. Changes of hepatitis B virus DNA in livers and sera were analyzed by the molecular hybridization technique in paired biopsies obtained before and 2 weeks after treatment. Serum hepatitis B virus DNA was examined before, during and after the treatment until 4 weeks post–interferon. Analysis of hepatic hepatitis B virus DNA revealed species that appeared to represent various forms of replicative hepatitis B virus DNA, i.e., relaxed circular, linear, supercoiled and single–stranded hepatitis B virus DNA, respectively. No evidence of integration of hepatitis B virus DNA in genomic DNA was obtained. Of 15 cases which were positive for hepatic hepatitis B virus DNA before treatment and in which paired biopsies were obtained, hepatic hepatitis B virus DNA became negative in 4, decreased in 5 and unchanged in 6. Among several types of replicative viral DNA in liver tissue, supercoiled hepatitis B virus DNA tended to remain after other forms were reduced. A close correlation between hepatic and serum hepatitis B virus DNA was found in 37 liver biopsy samples and corresponding sera. These results indicate that interferon treatment reduces serum hepatitis B virus levels by inhibiting viral replication in the liver and that persistence or reappearance of hepatitis B virus in serum after interferon is associated with replication.This publication has 39 references indexed in Scilit:
- Detection of Hepatitis B Virus DNA in Serum by a Simple Spot Hybridization Technique: Comparison with Results for Other Viral MarkersHepatology, 1983
- Detection of Hepatitis B Virus DNA Directly in Human Serum by a Simplified Molecular Hybridization Test: Comparison to HBeAg/ Anti-HBe Status in HBsAg Carriers†Hepatology, 1983
- The detection of hbv‐dna in serum by molecular hybridisation: A more sensitive method for the detection of complete hbv particlesJournal of Medical Virology, 1982
- Hepatitis B virus DNA in the sera of HBsAg carriers: A marker of active hepatitis B virus replication in the liverHepatology, 1981
- Adenine arabinoside therapy in HBsAg-positive chronic liver disease: A controlled studyGastroenterology, 1981
- Antiviral treatment of chronic hepatitis B virus infection: Improvement in liver disease with interferon and adenine arabinosideHepatology, 1981
- Hepatitis B Vaccine Passes First Major TestScience, 1980
- Long-term Follow-up of Chronic Hepatitis Patients with HBsAg, HBeAg and Dane Particle Associated DIMA Polymerase in SerumScandinavian Journal of Infectious Diseases, 1980
- Type B Hepatitis: The Infectivity of Blood Positive for E Antigen and DNA Polymerase after Accidental Needlestick ExposureNew England Journal of Medicine, 1976
- Effect of Human Leukocyte Interferon on Hepatitis B Virus Infection in Patients with Chronic Active HepatitisNew England Journal of Medicine, 1976